Ardelyx Gears Up for Secondary Offering
Ardelyx recently filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering.
All Work
Chris Lange
Collegium Pharmaceutical Prices Secondary Offering
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering.
Jaguar Animal Health Gears Up for Secondary Offering
Jaguar Animal Health has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for a secondary offering.
The 2016 Bullish and Bearish Case for Caterpillar and DuPont
For the most part the outlook is not exactly clear for Caterpillar or DuPont going into 2016. Both Dow stocks came out on the negative side in 2015.
The 2016 Bullish and Bearish Case for Disney
Walt Disney has been a top-performing Dow stock for years, and it seems like this company can do no wrong, the way that it left 2015.
The 2016 Bullish and Bearish Case for Home Depot
Strong fundamentals, earnings and a solid balance sheet made Home Depot a top performer in 2015. But will this performance carry over to 2016?
Bed Bath & Beyond Earnings Meet Estimates
Bed Bath & Beyond reported its fiscal third-quarter financial results and offered guidance after the markets closed on Thursday.
Dynavax Soars on Positive Late Stage Results
Dynavax Technologies led the bulls on Thursday with positive results from a late stage clinical trial, on another consecutive down day for the broad markets.
The 2016 Bullish and Bearish Case for Nike
Nike was the top-performing Dow component in 2015. The question is whether this company can have a repeat performance in 2016.
The 2016 Bullish and Bearish Case for McDonald’s
McDonald's stock has been on fire over the past six months, and it remains a solid pick for investors seeking dividends and a degree of safety. But how will this fast-food giant perform in…
The 2016 Bullish and Bearish Case for American Express and Visa
The major credit cards of the Dow had a somewhat mixed year, with Visa the obvious winner as a card processor, while American Express went south as a credit card issuer.
Finish Line Earnings Stumble Over Supply Chain Disruption
Finish Line reported disappointing fiscal third-quarter financial results before the markets opened on Thursday.
Macy’s Accommodates for Weak Holiday Sales With Cost-Efficient Initiatives
Macy's had a tough run over the holiday season and the company suffered, but no one thought that it might be this bad.
The 2016 Bullish and Bearish Case for Goldman Sachs and JPMorgan
If analysts end up being correct in 2016, the bank holding company stocks could bring double-digit gains in the year ahead.
What to Expect From Finish Line Earnings
Finish Line Inc. (NASDAQ: FINL) is scheduled to report its fiscal third quarter financial results before the markets open on Thursday. The consensus estimates call for a net loss per share of $0.04 on…
How Does an Argentine Bank IPO Sound?
Before readers think that this may be a hoax, it is not. How would most investors feel about buying into an Argentine financial group that owns a bank? After all, the financial history of…
JPMorgan Settles Misstatement With SEC for $4 Million
The SEC has announced that JPMorgan's brokerage business agreed to pay $4 million to settle charges of making false statements.
The 2016 Bullish and Bearish Case for Apple
24/7 Wall St. is looking forward to see what the strategists and analysts on Wall Street expect for the stock market and the major stocks in 2016, in this case Apple.
Visterra Readies for IPO
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.